Overexpression of Crry Protects Mesangial Cells from Complement-Mediated Injury

Journal of the American Society of Nephrology

Volumn 8, Issue 2, 1997, Pages 223-233

  Nangaku, Masaomi ^a   Quigg, Richard J ^b   Shankland, Stuart J ^a   Okada, Noriko ^c   Johnson, Richard J ^a   Couser, William G ^a,d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT RECEPTOR; CRRY PROTEIN, RAT; MEMBRANE ANTIGEN; PRIMER DNA;

ANIMAL; ARTICLE; CELL CULTURE; CYTOTOXICITY; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INJURY; MESANGIUM; METABOLISM; NUCLEOTIDE SEQUENCE; ONCOGENE MYC; PATHOLOGY; RAT;

ANIMALS; ANTIGENS, SURFACE; BASE SEQUENCE; CELLS, CULTURED; COMPLEMENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT SYSTEM PROTEINS; CYTOTOXICITY, IMMUNOLOGIC; DNA PRIMERS; GENE EXPRESSION; GENES, MYC; GLOMERULAR MESANGIUM; IMMUNOHISTOCHEMISTRY; RATS; RECEPTORS, CELL SURFACE; RECEPTORS, COMPLEMENT; TRANSFECTION;

EID: 0031067254     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Morgan BP: Physiology and pathophysiology of complement: Progress and trends. Crit Rev Clin Lab Sci 32: 265-298, 1995
2. Couser WG: The pathogenesis of glomerulonephritis. Kidney Int 42: S19-S26, 1993
3. Couser WG: Mechanisms of glomerular injury in immune-complex disease. Kidney Int 28: 569-583, 1985
4. Hebert LA, Cosio FG, Birmingham DJ: The role of complement system in renal injury. Semin Nephrol 12: 408-427, 1992
5. Couser WG, Schulze M, Pruchno CJ: Role of C5b-9 in experimental membranous nephropathy. Nephrol Dial Transplant 7: S25-31, 1992
6. Morgan BP, Men S: Membrane proteins that protect against complement lysis. Spring Sem Immunopathol 15: 369-396, 1994
7. Seya T, Turner J, Atkinson JP: Purification and characterization of membrane cofactor protein (gp45-70) which is a cofactor for cleavage of C3b and C4b. J Exp Med 163: 837-855, 1986
8. Johnstone RW, Loveland BE, McKenzie IFC: Identification and quantification of complement regulator CD46 on normal human tissues. Immunology 79: 341-347, 1993
9. Endoh M, Yamashina M, Ohi H, Funahashi K, Ikuno T, Yasugi T, Atkinson JP, Okada H: Immunohistochemical demonstration of membrane cofactor protein (MCP) of complement in normal and diseased kidney tissues. Clin Exp Immunol 94: 182-188, 1993
10. Liszewski MK, Post TW, Atkinson JP: Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu Rev Immunol 9: 431-455, 1991
11. Nicholson-Weller A, Burge J, Fearson DT, Weller PF, Austen KF: Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol 129: 184-189, 1982
12. Cosio FG, Sedmak DD, Mahan JD, Nahman NS, Jr: Localization of decay accelerating factor in normal and diseased kidneys. Kidney Int 36: 100-107, 1989
13. Nicholson-Weller A, Wang C: Structure and function of decay accelerating factor CD55. J Lab Clin Med 123: 485-491, 1994
14. Ichida S, Yuzawa Y, Okada H, Yoshioka K, Matsuo S: Localization of the complement regulatory proteins in the normal human kidney. Kidney Int 46: 89-96, 1994
15. Tamai H, Matsuo S, Fukatsu A, Nishikawa K, Sakamoto N, Yoshioka K, Okada N, Okada H: Localization of 20-kD homologous restriction factor (HRF20) in diseased human glomeruli. an immunofluorescence study. Clin Exp Immunol 84: 256-262, 1991
16. Oglesby TJ, Allen CJ, Liszewski MK, White DJG, Atkinson JP: Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J Exp Med 175: 1547-1551, 1992
17. Rollins SA, Sims PJ: The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J Immunol 144: 3478-3483, 1990
18. Meri S, Morgan BP, Davies A, Daniels RH, Olavesen MG, Waldmann H, Lachmann PJ: Human protectin (CD59), and 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 71: 1-9, 1990
19. Okada N, Harada R, Fujita T, Okada H: A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement. Int Immunol 1: 205-208, 1989
20. Harada R, Okada N, Fujita T, Okada H: Purification of 1F5 antigen which prevents complement attack on homologous cell membranes. J Immunol 144: 1823-1828, 1990
21. Hourcade D, Holers VM, Atkinson JP: The regulators of complement activation (RCA) gene cluster. Adv Immunol 45: 381-416, 1989
22. Krych M, Atkinson JP, Holers VM: Complement receptors. Curr Opin Immunol 4: 8-13, 1992
23. Holers VM, Kinoshita T, Molina H: The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function. Immunol Today 13: 231-236, 1992
24. Reid KB, Day AJ: Structure-function relationships of the complement components. Immunol Today 10: 177-180, 1989
25. Li B, Sallee C, Dehoff M, Foley S, Molina H, Holers VM: Mouse Crry/p65. characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J Immunol 151: 4295-4305, 1993
26. Molina H, Wong W, Kinoshita T, Brenner C, Foley S, Holers VM: Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1. J Exp Med 175: 121-129, 1992
27. Foley S, Li B, Dehoff M, Molina H, Holers VM: Mouse Crry/ p65 is a regulator of the alternative pathway of complement activation. J Immunol 23: 1381-1384, 1993
28. Kim Y, Kinoshita T, Molina H, Hourcade D, Seya T, Wagner LM. Holers VM: Mouse complement regulatory protein Crry/ p65 utilizes the specific mechanisms of both human decay-accelerating factor (DAF) and membrane cofactor protein (MCP). J Exp Med 181: 151-159, 1995
29. Paul MS, Aegerter M O'Brien SE, Kurtz CB, Weis JH: The murine complement receptor gene family: analysis of mCRY gene products and their homology to human CR1. J Immunol 142: 582-589, 1989
30. Quigg RJ, Holers VM, Morgan BP, Sneed III AE: Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody to passive Heymann nephritis. J Immunol 154: 3437-3443, 1995
31. Quigg RJ, Morgan BP, Holers VM, Adler S, Sneed III AE, Lo CF: Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in glomerular mesangial and endothelial cells. Kidney Int 48: 412-421, 1995
32. Funabashi K, Okada N, Matsuo S, Yamamoto T, Morgan BP, Okada H: Tissue distribution of complement regulatory membrane proteins in rats. Immunology 81: 444-451, 1994
33. Quigg RJ, Lo CF, Alexander JJ, Sneed III AE, Moxley G: Molecular characterization of rat Crry: widespread distribution of two alternative forms of Crry mRNA. Immunogenetics 42: 362-367, 1995
34. Kozak M: Structural features in eukaryotic mRNAs that modulate the initiation of translation. J Biol Chem 266: 19867-19870, 1991
35. Kozak M: The scanning model for translation: An update. J Cell Biol 108: 229-241, 1989
36. Niwa H, Yamamura K, Miyazaki J: Efficient selection for high-expression transfectants by a novel eukaryotic vector. Gene 108: 193-200, 1991
37. McHugh KM, Lessard JL: The nucleotide seqeunce of a rat vascular smooth muscle. Nucleic Acid Res 16: 4167, 1988
38. Nangaku M, Meek RL, Pippin J, Gordon KL, Morgan BP, Johnson RJ, Couser WG: Transfected CD59 protects mesangial cells from injury induced by antibody and complement. Kidney Int 50: 257-266, 1996
39. Adler S, Baker PJ, Johnson RJ, Ochi RF, Pritzl P, Couser WG: Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest 77: 762-767, 1986
40. Takizawa H, Okada N, Okada H: Complement inhibitor of rat cell membrane resembling mouse Crry/p65. J Immunol 152-3032-3038, 1994
41. Schulze M, Baker PJ, Perkinson DT, Johnson RJ, Ochi RF, Stahl RAK, Couser WG: Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat. Kidney Int 35: 60-68, 1989
42. Nangaku M, Pippin J, Richardson CA, Schulze M, Young BA, Alpers CE, Gordon KL, Johnson RJ, Couser WG: Beneficial effects of systemic immunoglobulin in experimental membranous nephropathy. Kidney Int, in press.
43. Russo C, Callegaro L, Lanza E, Ferrone S: Purification of IgG monoclonal antibody by caprylic acid precipitation. J Immunol Methods 65: 269-271, 1983
44. Matsuo S, Ichida S, Takizawa H, Okada N, Baranyi L, Iguchi A, Morgan BP, Okada H: In vivo effects of monoclonal antibodies which functionally inhibit complement regulatory proteins in rats. J Exp Med 180: 1619-1627, 1994
45. Wroblewski F, LaDue JS: Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med 90: 210-213, 1955
46. Salant DJ, Quigg RJ, Cybulsky AV: Heymann nephritis: Mechanisms of renal injury. Kidney Int 35: 976-984, 1989
47. Asghar SS: Membrane regulators of complement activation and their aberrant expression in disease. Lab Invest 72: 254-271, 1995
48. Wong WW, Fearon DT: p65: A C3b-binding protein on murine cells that shares antigenic determinants with the human C3b receptor (CR1) and is distinct from murine C3b receptor. J Immunol 134: 4048-4056, 1985
49. Angerter-Shaw M, Cole JL, Klickstein LB, Wong WW, Fearon DT, Lalley PA, Weis JH: Expansion of the complement receptor gene family. Identification in the mouse of two new genes related to the CR1 and CR2 gene family. J Immunol 138: 3488-3494, 1987
50. Paul MS, Aegerter M, Cepek K, Miller MD, Weis JH: The murine complement receptor gene family. III. The genomic and transcriptional complexity of the Crry and Crry-ps genes. J Immunol 144: 1988-1996, 1990
51. Sakurada C, Seno H, Dohi N, Takizawa H, Nonaka M, Okada N, Okada H: Molecular cloning of the rat complement regulatory protein, 512 antigen. Biochem Biophys Res Commun 198: 819-826, 1994
52. Quigg RJ, Sneed III AE: Molecular characterization of rat glomerular epithelial cell complement receptors. J Am Soc Nephrol 4: 1912-1919, 1994
53. Nomura A, Nishikawa K, Yuzawa Y, Okada H, Okada N, Morgan BP, Piddlesden SJ, Nadai M, Hasegawa T, Matsuo S: Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement. J Clin Invest 96: 2348-2356, 1995
54. Nishikage H, Baranyi L, Okada H, Okada N, Isobe K, Nomura A, Yoshida F, Matsuo S: The role of a complement regulatory protein in rat mesangial glomerulonephritis. J Am Soc Nephrol 6: 234-242, 1995
55. Yamamoto T, Wilson CB: Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat. Kidney Int 32: 514-525, 1987
56. Yamamoto T, Wilson CB: Complement dependence of antibody-induced mesangial cell injury in the rat. J Immunol 138: 3758-3765, 1987
57. Johnson RJ, Pritzl P, Iida H, Alpers CE: Platelet-complement interactions in mesangial proliferative nephritis in the rat. Am J Pathol 138: 313-321, 1991
58. Brandt J, Pippin J, Schulze M, Hänsch GM, Alpers C, Johnson RJ, Gordon K, Couser WG: Role of the complement membrane attack complex (C5b-9) mediating experimental mesangioproliferative glomerulonephritis. Kidney Int 49: 335-343, 1996
59. Hänsch GM, Schieren G, Wagner C, Schonermark M: Immune damage to the mesangium: Antibody- and complement-mediated stimulation and destruction of mesangial cells. J Am Soc Nephrol 2: S139-S143, 1992
60. Lovett DH, Hänsch GM, Goppelt M, Resch K, Gemsa D: Activation of glomerular mesangial cells by the terminal membrane attack complex of complement. J Immunol 138: 2473-2480, 1987
61. Torbohm I, Schonermark M, Wingen AM, Berger B, Rother K, Hänsch GM: C5b-8 and C5b-9 modulate the collagen release of human glomerular epithelial cells. Kidney Int 37: 1098-1104, 1990
62. Schonermark M, Deppisch R, Riedasch G, Rother K, Hänsch GM: Induction of mediator release from human glomerular mesangial cells by the terminal membrane attack components C5b-9. Int Arch Allergy Appl Immunol 96: 331-337, 1991
63. Shah SV: Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 35: 1093-1106, 1989
64. Couser WG, Johnson RJ, Young BA, Yeh G, Toth CA, Rudolph AR: The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritis. J Am Soc Nephrol 5: 1888-1894, 1995